Comprehensive Biomarker Center GmbH Accredited by German DAkkS
News May 22, 2015
As of April 1, 2015 the Comprehensive Biomarker Center GmbH has been accredited according to DIN EN ISO/IEC 17025:2005 from the national accreditation body for the Federal Republic of Germany (DAkkS). The independent governmental institution has acknowledged the high quality standard of CBC’s biomarker services on the Agilent microarray platform.
Based in Heidelberg, Germany, CBC has been accredited for its expertise in the extraction of total RNA from body fluids and the analysis of microRNA & mRNA using the Agilent microarray platform.
Jochen Kohlhaas, chief executive officer at CBC GmbH, commented: “I am very proud that CBC has received DIN EN ISO/IEC 17025:2005 accreditation. This reflects our commitment to our clients and the dedication of our laboratory staff. It is a strong endorsement of the high quality of our services.”
“The potential of microRNA biomarkers in disease detection and monitoring, as well as companion diagnostics is increasingly recognized. As an accredited biomarker company, we provide reliable and continuously high quality in our methods, technologies and data quality of the analysis service. Having DIN EN ISO/IEC 17025:2005 accreditation demonstrates CBC’s competency to conduct testing to the highest standards and the strength of our quality management system” said Karoly Nikolich, chairman of CBC’s board and renowned biotechnology expert.” The accreditation allows customers to compare the quality of service providers in the microRNA Biomarker field.”
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE
Genetics Help Make a Weed a WeedNews
A study has has found that the success of weedy and invasive plants like the Jerusalem artichoke lies in their genes. Understanding how invasive plants evolve and the genes that enable them to thrive in a new environment is key to better understanding why they are wreaking havoc on natural landscapes and food production around the world.READ MORE